Retractable Technologies Inc (RVP)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $16.76M
Last updated: Nov 17, 2026 at 10:15 AM ET
Retractable Technologies Inc (RVP) Financials: Revenue, Profit and Cash Flow
Retractable Technologies reported revenue of $38.27M for the fiscal year ended Dec 31, 2025, up 15.8% from the year before. That year, net income was -$12.57M with a net margin of -32.8%, operating cash flow was -$7.06M and free cash flow was -$7.60M. The quarter ended Sep 30, 2026 had revenue of $14.13M and net income of -$2.36M.
Revenue and Margins
The operating margin was -55.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $29.83M, a compound annual rate of 2.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $38.27M | +15.8% | 0.1% | -55.3% | -32.8% |
| Dec 2024 | $33.05M | -24.2% | -3.1% | -63.9% | -36.0% |
| Dec 2023 | $43.60M | -54.0% | 20.9% | -26.4% | -16.1% |
| Dec 2022 | $94.82M | -49.7% | 29.8% | -0.9% | 5.4% |
| Dec 2021 | $188.38M | +130.1% | 50.6% | 38.5% | 29.8% |
| Dec 2020 | $81.86M | +95.9% | 45.2% | 29.4% | 29.6% |
| Dec 2019 | $41.80M | +25.6% | 33.8% | 7.1% | 7.5% |
| Dec 2018 | $33.27M | -3.5% | 30.7% | -4.0% | -4.0% |
| Dec 2017 | $34.49M | +15.6% | 100.0% | -11.0% | -10.8% |
| Dec 2016 | $29.83M | N/A | 100.0% | -11.8% | -12.4% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.27M | $33.05M | $43.60M | $94.82M | $188.38M | $81.86M | $41.80M | $33.27M | $34.49M | $29.83M |
| Cost of revenue | $38.22M | $34.08M | $34.49M | $66.57M | $93.03M | $44.85M | $27.66M | $23.05M | $0 | $0 |
| Gross profit | $47.05K | -$1.03M | $9.11M | $28.25M | $95.35M | $37.01M | $14.14M | $10.22M | $34.49M | $29.83M |
| Research and development | $675.57K | $673.94K | $581.17K | $525.73K | $901.38K | $574.53K | $516.10K | $621.37K | $740.57K | $571.84K |
| Operating income | -$21.18M | -$21.11M | -$11.49M | -$852.98K | $72.60M | $24.07M | $2.97M | -$1.33M | -$3.78M | -$3.51M |
| Net income | -$12.57M | -$11.89M | -$7.01M | $5.08M | $56.06M | $24.22M | $3.15M | -$1.34M | -$3.74M | -$3.69M |
| EBITDA | -$10.59M | -$7.64M | $2.26M | $7.58M | $74.28M | $26.77M | $3.82M | -$442.72K | -$2.94M | -$2.63M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.13M | $7.20M | $7.18M | $9.44M | $10.09M | $10.45M | $8.30M | $9.07M | $10.35M | $6.03M | $7.60M | $14.29M |
| Gross profit | $193.25K | $190.85K | -$838.41K | -$1.53M | $1.69M | -$107.09K | -$1.91K | -$2.49M | -$14.81K | -$419.92K | $1.90M | $1.54M |
| Operating income | -$4.14M | -$5.15M | -$6.17M | -$7.71M | -$3.65M | -$5.13M | -$4.68M | -$7.22M | -$5.14M | -$5.76M | -$2.99M | -$2.78M |
| Net income | -$2.36M | $2.83M | -$4.23M | -$2.35M | $371.05K | -$87.47K | -$10.50M | $3.77M | -$1.92M | -$14.16M | $429.38K | -$72.94K |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $895.64K by $1.69M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $142.63M | $160.72M | $179.67M | $195.67M | $206.30M | $104.97M | $45.84M | $36.96M | $38.16M | $38.78M |
| Current assets | $63.08M | $73.27M | $77.65M | $88.81M | $104.51M | $69.48M | $28.41M | $25.84M | $26.61M | $26.68M |
| Cash and equivalents | $2.59M | $4.24M | $12.67M | $19.72M | $29.16M | $17.57M | $5.93M | $9.65M | $14.88M | $16.20M |
| Total liabilities | $68.26M | $73.55M | $80.38M | $89.13M | $107.14M | $55.09M | $17.29M | $11.34M | $10.98M | $10.67M |
| Short-term debt | $365.28K | $332.48K | $303.99K | $285.95K | $289.11K | $1.03M | $343.30K | $406.36K | $410.95K | $430.39K |
| Long-term debt | $530.37K | $900.04K | $1.23M | $1.53M | $1.81M | $2.71M | $2.38M | $2.64M | $3.08M | $3.50M |
| Shareholder equity | $74.38M | $87.17M | $99.29M | $106.54M | $99.17M | $49.88M | $28.54M | $25.61M | $27.17M | $28.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $138.55M | $141.69M | $137.60M | $142.63M | $146.43M | $147.09M | $149.31M | $160.72M | $157.81M | $160.74M | $175.98M | $179.67M |
| Total liabilities | $68.10M | $68.83M | $67.50M | $68.26M | $69.65M | $70.62M | $72.70M | $73.55M | $74.35M | $75.31M | $76.32M | $80.38M |
| Cash and equivalents | $1.89M | $2.64M | $2.77M | $2.59M | $3.44M | $3.04M | $3.38M | $4.24M | $3.92M | $6.85M | $10.01M | $12.67M |
| Shareholder equity | $70.45M | $72.87M | $70.09M | $74.38M | $76.78M | $76.47M | $76.61M | $87.17M | $83.46M | $85.44M | $99.66M | $99.29M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.06M | -$11.56M | $2.77M | $16.77M | $32.79M | $19.00M | $2.19M | -$1.20M | -$2.92M | -$794.91K |
| Capital expenditures | $535.64K | $1.44M | $852.98K | $16.83M | $58.37M | $21.05M | $632.08K | $382.16K | $91.88K | $1.95M |
| Free cash flow | -$7.60M | -$13.00M | $1.91M | -$61.95K | -$25.57M | -$2.05M | $1.56M | -$1.58M | -$3.01M | -$2.74M |
| Dividends paid | $230.44K | $230.44K | $232.44K | $252.88K | $3.82M | $216.64K | $219.82K | $220.45K | $220.45K | $220.75K |
| Share repurchases | N/A | N/A | N/A | $7.62M | $5.27M | $0 | $0 | N/A | N/A | N/A |
| Investing cash flow | $5.98M | $3.66M | -$10.76M | -$31.20M | -$63.04M | -$19.33M | -$5.28M | -$3.37M | -$91.88K | -$1.95M |
| Financing cash flow | -$567.32K | -$535.43K | $941.64K | $4.99M | $41.84M | $11.96M | -$626.84K | -$666.80K | $1.69M | $896.08K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$248.23K | -$1.73M | -$1.37M | -$596.54K | -$1.26M | -$3.73M | -$1.48M | -$1.10M | -$5.73M | -$2.70M | -$2.02M | $1.89M |
| Capital expenditures | $53.57K | $29.82K | $6.23K | $26.57K | $89.79K | $332.25K | $87.03K | $298.06K | $793.78K | $121.70K | $226.40K | $153.70K |
| Free cash flow | -$301.80K | -$1.76M | -$1.37M | -$623.11K | -$1.35M | -$4.07M | -$1.56M | -$1.40M | -$6.52M | -$2.82M | -$2.25M | $1.74M |
Frequently Asked Questions About RVP
What is Retractable Technologies' annual revenue?
Retractable Technologies reported revenue of $38.27M for the fiscal year ended Dec 31, 2025.
How fast is Retractable Technologies' revenue growing?
Revenue was up 15.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -26.1%.
Is Retractable Technologies profitable?
No. Retractable Technologies reported net income of -$12.57M for the fiscal year ended Dec 31, 2025, with a net margin of -32.8%.
How much free cash flow does RVP generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$7.06M minus capital expenditures of $535.64K produced free cash flow of -$7.60M.
How much debt does Retractable Technologies have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $530.37K, short-term debt of $365.28K and cash and equivalents of $2.59M.
RVP pages: Overview, Earnings, Financials, Competitors, Government Contracts